Mahana Parallel Digital Cognitive Behavioral Therapy (CBT) Mobile Application for Irritable Bowel Syndrome (IBS)
K211372 is the FDA 510(k) clearance record for Mahana Parallel Digital Cognitive Behavioral Therapy (CBT) Mobile Application for Irritable Bowel Syndrome (IBS), a class II device, cleared for Mahana Therapeutics, Inc. on under FDA product code QMY (Computerized Behavioral Therapy Device For Treating Symptoms). FDA's definition for product code QMY reads: "A computerized behavioral therapy device for treating symptoms of gastrointestinal conditions is a prescription device intended to provide a computerized version of condition-specific therapy as an adjunct to standard of care treatments to...". FDA records list 2 510(k) clearances for Mahana Therapeutics, Inc., from to . As of , FDA records show no recalls naming K211372.
Clearance record
- Decision date
- Received
- (29 days to decision)
- Product code
- QMY Computerized Behavioral Therapy Device For Treating Symptoms
- Regulation
- 21 CFR 876.5960
- Device class
- Class II
- Review panel
- Gastroenterology, Urology
- Applicant
- Mahana Therapeutics, Inc. One Market, Spear Tower 36th Floor, San Francisco CA
- 510(k) summary
- Summary PDF
- Third party review
- No
Clearances, product code QMY
Trailing 12 monthsFDA records hold no clearances under product code QMY in the trailing twelve months.
Show the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
